39 related articles for article (PubMed ID: 1521438)
21. [Definition, concept and pathophysiology of pulmonary hypertension].
Kunieda T
Nihon Rinsho; 2001 Jun; 59(6):1037-46. PubMed ID: 11411110
[TBL] [Abstract][Full Text] [Related]
22. Prostacyclin and PGE1 treatment of pulmonary hypertension.
Long WA; Rubin LJ
Am Rev Respir Dis; 1987 Sep; 136(3):773-6. PubMed ID: 3307575
[TBL] [Abstract][Full Text] [Related]
23. Nursing considerations in the care of patients with pulmonary hypertension.
Nieves JA; Kohr L
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S74-8. PubMed ID: 20216168
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary arterial hypertension associated with bronchopulmonary dysplasia and congenital heart disease in preterm infants. A case report of a preterm infant with recurrent pulmonary hypertension after corrective cardiac surgery and review of the literature.
Muneuchi J; Kuraoka A; Watanabe M; Ochiai Y; Joo K
Int Heart J; 2015; 56 Suppl():S22-5. PubMed ID: 25787794
[TBL] [Abstract][Full Text] [Related]
25. Prostacyclins in Cardiac Surgery: Coming of Age.
Deshpande SP; Mazzeffi MA; Strauss E; Hollis A; Tanaka KA
Semin Cardiothorac Vasc Anesth; 2018 Sep; 22(3):306-323. PubMed ID: 29277148
[TBL] [Abstract][Full Text] [Related]
26. Is nebulised tolazoline an effective treatment for persistent pulmonary hypertension of the newborn?
Hartigan D
Arch Dis Child; 2003 Jan; 88(1):84. PubMed ID: 12495975
[No Abstract] [Full Text] [Related]
27. Hemodynamic responses to perioperative pain and stress in infants.
Wessel DL
Crit Care Med; 1993 Sep; 21(9 Suppl):S361-2. PubMed ID: 8365227
[No Abstract] [Full Text] [Related]
28. Anesthetic drugs in congenital heart disease.
Friesen RH
Semin Cardiothorac Vasc Anesth; 2014 Dec; 18(4):363-70. PubMed ID: 25053242
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for epoprostenol in the management of heart failure?
Haywood GA; Adams KF; Gheorghiade M; McKenna WJ
Am J Cardiol; 1995 Jan; 75(3):44A-50A. PubMed ID: 7840054
[TBL] [Abstract][Full Text] [Related]
30. Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients.
Scheeren T; Radermacher P
Intensive Care Med; 1997 Feb; 23(2):146-58. PubMed ID: 9068999
[No Abstract] [Full Text] [Related]
31. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
32. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T; Nakayama T; Ishikita T; Matsuura H
Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
[TBL] [Abstract][Full Text] [Related]
33. [Continuous intravenous prostacyclin therapy].
Miyaji K; Matsubara H
Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
[TBL] [Abstract][Full Text] [Related]
34. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery.
Lowson SM; Doctor A; Walsh BK; Doorley PA
Crit Care Med; 2002 Dec; 30(12):2762-4. PubMed ID: 12483070
[TBL] [Abstract][Full Text] [Related]
35. Epoprostenol sodium for treatment of pulmonary arterial hypertension.
Saito Y; Nakamura K; Akagi S; Sarashina T; Ejiri K; Miura A; Ogawa A; Matsubara H; Ito H
Vasc Health Risk Manag; 2015; 11():265-70. PubMed ID: 25999730
[TBL] [Abstract][Full Text] [Related]
36. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?
Beghetti M; Galiè N; Bonnet D
Congenit Heart Dis; 2012; 7(1):3-11. PubMed ID: 22233186
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
